March 26, 2020 / 8:20 PM / in 7 days

BRIEF-Therapeuticsmd Inc - Does Not Anticipate A Shortage Of Its Products Due To Covid-19 At This Time

TherapeuticsMD Inc:

* SEES Q1 2020 REVENUE MORE THAN $11 MILLION

* THERAPEUTICSMD - STRONG PRELIMINARY Q1 2020 TOTAL NET REVENUE PROJECTED TO BE MORE THAN $11 MILLION

* IMPLEMENTING STAGED CONTINGENCY PLAN THAT CAN BE ADJUSTED AS COVID-19 SITUATION EVOLVES

* COVID-19 CONTINGENCY PLAN IS DESIGNED TO BE IMPLEMENTED IN STAGES OVER SECOND AND THIRD QUARTERS OF 2020

* SUSPENDING ITS FULL-YEAR 2020 FINANCIAL GUIDANCE THAT WAS PREVIOUSLY PROVIDED IN FEBRUARY 2020

* THERAPEUTICSMD - BELIEVES THAT ITS VITACARE PRESCRIPTION SERVICES PATIENT MODEL WILL SUPPORT CONTINUED PATIENT ACCESS TO CO’S PRODUCTS DURING COVID-19 PANDEMIC

* DOES NOT ANTICIPATE A SHORTAGE OF ITS PRODUCTS DUE TO COVID-19 AT THIS TIME

* IMPLEMENTING MEASURES TO INITIALLY CUT OR DEFER MORE THAN $30 MILLION IN ANNUAL SPENDING Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below